{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:10:26Z","timestamp":1790669426101,"version":"4.1.0"},"reference-count":78,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2023,5,26]]},"DOI":"10.18632\/oncotarget.28442","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:14:08Z","timestamp":1685114048000},"page":"528-541","source":"Crossref","is-referenced-by-count":4,"title":["Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression"],"prefix":"10.18632","volume":"14","author":[{"given":"Mohammad Salman","family":"Akhtar","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia"},{"name":"Department of Biosciences, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Akhter","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, India"},{"name":"Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Talat","sequence":"additional","affiliation":[{"name":"Department of Orthodontics and Dentofacial Orthopedics, ITS Dental College, Hospital and Research Centre, Greater Noida, Delhi-NCR, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed A.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed A.A.","family":"Sindi","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Klufah","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan E.","family":"Alyahyawi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsen","family":"Alruwetei","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, College of Applied Medical Sciences, Qassim University, Qassim, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin A.","family":"Zamzami","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SVS","family":"Deo","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, BRA- IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Akhtar","family":"Husain","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Badi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Jahir","family":"Khan","sequence":"additional","affiliation":[{"name":"School of Biotechnology, Jawahar Lal Nehru University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/medsci8010018","article-title":"Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments","volume":"8","author":"Pelosi","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"13","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.26355\/eurrev_202106_26131","article-title":"Crosstalk of Cyclin-dependent kinase inhibitor 1A (CDKN1A) gene polymorphism with p53 and CCND1 polymorphism in breast cancer","volume":"2","author":"Ahmad","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"5","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"14","author":"Bray","year":"2019","journal-title":"Int J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/bcr2832","article-title":"Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals","volume":"1","author":"Sallinen","year":"2011","journal-title":"Breast Cancer Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1677\/erc.1.01038","article-title":"Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition","volume":"1","author":"van Gils","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"8","first-page":"1469","article-title":"Aberrant p16 promoter hypermethylation in bronchial mucosae as a biomarker for the early detection of lung cancer","volume":"11","author":"Cheng","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/s0168-9525(01)02366-6","article-title":"CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease","volume":"1","author":"Lobanenkov","year":"2001","journal-title":"Trends Genet"},{"key":"10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2009.06.001","article-title":"CTCF: master weaver of the genome","volume":"13","author":"Corces","year":"2009","journal-title":"Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1073\/pnas.092123699","article-title":"BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma","volume":"9","author":"Rasko","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Old","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.bjc.6604181","article-title":"BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours","volume":"9","author":"Klenova","year":"2008","journal-title":"Br J Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1158\/0008-5472.CAN-05-0858","article-title":"Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes","volume":"6","author":"Lobanenkov","year":"2005","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-05-2569","article-title":"Global expression analysis of cancer\/testis genes in uterine cancers reveals a high incidence of BORIS expression","volume":"1","author":"Barrett","year":"2007","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/dna.2011.1248","article-title":"Analysis of promoter methylation and polymorphic minisatellites of BORIS and lack of association with gastric cancer","volume":"3","author":"Leem","year":"2011","journal-title":"DNA Cell Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1158\/1078-0432.CCR-05-2731","article-title":"The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis","volume":"1","author":"Klenova","year":"2006","journal-title":"Clin Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/ht7040030","article-title":"Molecular Lesions of Insulator CTCF and Its Paralogue CTCFL (BORIS) in Cancer: An Analysis from Published Genomic Studies","volume":"7","author":"Voutsadakis","year":"2018","journal-title":"High Throughput"},{"key":"19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3892\/ol.2020.12114","article-title":"Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer","volume":"2","author":"Wang","year":"2020","journal-title":"Oncol Lett"},{"key":"20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.celrep.2014.04.004","article-title":"CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer","volume":"7","author":"Liggitt","year":"2014","journal-title":"Cell Rep"},{"key":"21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbrc.2008.03.040","article-title":"Selective apoptosis of breast cancer cells by siRNA targeting of BORIS","volume":"37","author":"Reznik","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"22","doi-asserted-by":"publisher","first-page":"e40389","DOI":"10.1371\/journal.pone.0040389","article-title":"Dose-dependent activation of putative oncogene SBSN by BORIS","volume":"7","author":"Califano","year":"2012","journal-title":"PLoS One"},{"key":"23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2017.06.017","article-title":"BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells","volume":"40","author":"Li","year":"2017","journal-title":"Cancer Lett"},{"key":"24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/nar\/gkq827","article-title":"BORIS\/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells","volume":"3","author":"Benhattar","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1593\/neo.121948","article-title":"A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells","volume":"1","author":"Klenova","year":"2013","journal-title":"Neoplasia"},{"key":"26","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1158\/0008-5472.CAN-03-3498","article-title":"Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis","volume":"6","author":"Klenova","year":"2005","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.ejca.2011.09.009","article-title":"BORIS in human cancers -- a review","volume":"4","author":"Martin-Kleiner","year":"2012","journal-title":"Eur J Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1158\/0008-5472.CAN-07-6654","article-title":"DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL\/BORIS and modulation of promoter histone methylation","volume":"6","author":"Gius","year":"2008","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.bbagrm.2014.06.017","article-title":"The epigenetic factor BORIS\/CTCFL regulates the NOTCH3 gene expression in cancer cells","volume":"183","author":"Caiafa","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"30","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1093\/nar\/gky483","article-title":"Choice of binding sites for CTCFL compared to CTCF is driven by chromatin and by sequence preference","volume":"4","author":"Renkawitz","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13059-015-0736-8","article-title":"Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions","volume":"1","author":"Strunnikov","year":"2015","journal-title":"Genome Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-8935-5-8","article-title":"The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner","volume":"5","author":"van Ijcken","year":"2012","journal-title":"Epigenetics Chromatin"},{"key":"33","doi-asserted-by":"publisher","first-page":"e1000169","DOI":"10.1371\/journal.pgen.1000169","article-title":"The evolution of epigenetic regulators CTCF and BORIS\/CTCFL in amniotes","volume":"4","author":"Marshall Graves","year":"2008","journal-title":"PLoS Genet"},{"key":"34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1034\/j.1600-065x.2002.18803.x","article-title":"Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy","volume":"18","author":"Chen","year":"2002","journal-title":"Immunol Rev"},{"key":"35","first-page":"1","article-title":"The cancer\/testis genes: review, standardization, and commentary","volume":"4","author":"Old","year":"2004","journal-title":"Cancer Immun"},{"key":"36","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1128\/MCB.01093-09","article-title":"Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS","volume":"3","author":"Lobanenkov","year":"2010","journal-title":"Mol Cell Biol"},{"key":"37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12935-018-0650-8","article-title":"BORIS: a key regulator of cancer stemness","volume":"1","author":"Dehghani","year":"2018","journal-title":"Cancer Cell Int"},{"key":"38","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1158\/1078-0432.CCR-11-0653","article-title":"BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer","volume":"1","author":"Califano","year":"2011","journal-title":"Clin Cancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.1158\/0008-5472.CAN-05-0823","article-title":"Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells","volume":"6","author":"Zhao","year":"2005","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1038\/sj.onc.1210218","article-title":"Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells","volume":"2","author":"Schrump","year":"2007","journal-title":"Oncogene"},{"key":"41","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1349-7006.2012.02355.x","article-title":"Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer","volume":"10","author":"Kawakami","year":"2012","journal-title":"Cancer Sci"},{"key":"42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gene.2017.07.077","article-title":"Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma","volume":"62","author":"Qin","year":"2017","journal-title":"Gene"},{"key":"43","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1158\/1541-7786.MCR-19-0310","article-title":"Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through","volume":"1","author":"Higgins","year":"2019","journal-title":"Mol Cancer Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41389-019-0150-2","article-title":"The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer","volume":"8","author":"Soto-Reyes","year":"2019","journal-title":"Oncogenesis"},{"key":"45","first-page":"21","article-title":"DNA methylation-dependent regulation of BORIS\/CTCFL expression in ovarian cancer","volume":"7","author":"Karpf","year":"2007","journal-title":"Cancer Immun"},{"key":"46","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1158\/1078-0432.CCR-10-2315","article-title":"Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS\/CTCF expression ratio and advanced stage","volume":"1","author":"Karpf","year":"2011","journal-title":"Clin Cancer Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/pros.22738","article-title":"Expression of the cancer-testis antigen BORIS correlates with prostate cancer","volume":"7","author":"Klenova","year":"2014","journal-title":"Prostate"},{"key":"48","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.bcp.2006.06.020","article-title":"Epigenetic control of CTCFL\/BORIS and OCT4 expression in urogenital malignancies","volume":"7","author":"Schulz","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"49","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-019-1472-0","article-title":"BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells","volume":"57","author":"Gray","year":"2019","journal-title":"Nature"},{"key":"50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s1044-579x(02)00060-3","article-title":"The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer","volume":"1","author":"Lobanenkov","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"51","doi-asserted-by":"publisher","first-page":"e13872","DOI":"10.1371\/journal.pone.0013872","article-title":"The structural complexity of the human BORIS gene in gametogenesis and cancer","volume":"5","author":"Lobanenkov","year":"2010","journal-title":"PLoS One"},{"key":"52","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"1","author":"Matrisian","year":"2009","journal-title":"Clin Cancer Res"},{"key":"53","first-page":"4257","article-title":"Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes","volume":"5","author":"Kuo","year":"1994","journal-title":"Cancer Res"},{"key":"54","first-page":"304","article-title":"Dominant genetic alterations in immortalization: role for 20q gain","volume":"2","author":"Reznikoff","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"55","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1371\/journal.pbio.0040355","article-title":"The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation","volume":"4","author":"Shaw","year":"2006","journal-title":"PLoS Biol"},{"key":"56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13059-020-02056-6","article-title":"Author Correction: Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation","volume":"2","author":"Skok","year":"2020","journal-title":"Genome Biol"},{"key":"57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13072-016-0084-2","article-title":"The cancer-associated CTCFL\/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements","volume":"9","author":"Strunnikov","year":"2016","journal-title":"Epigenetics Chromatin"},{"key":"58","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/ijc.28184","article-title":"The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells","volume":"13","author":"Rasko","year":"2013","journal-title":"Int J Cancer"},{"key":"59","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jsps.2020.03.013","article-title":"Association of mutation and low expression of thegene with breast cancer progression","volume":"2","author":"Husain","year":"2020","journal-title":"Saudi Pharm J"},{"key":"60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"Perou","year":"2011","journal-title":"Mol Oncol"},{"key":"61","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s12253-014-9749-y","article-title":"Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study","volume":"2","author":"Gall Tro\u0161elj","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"636","DOI":"10.18632\/oncotarget.950","article-title":"Expression of cancer\/testis antigens is correlated with improved survival in glioblastoma","volume":"4","author":"Vettore","year":"2013","journal-title":"Oncotarget"},{"key":"63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gde.2013.10.011","article-title":"CTCF and BORIS in genome regulation and cancer","volume":"2","author":"Rasko","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"64","doi-asserted-by":"publisher","first-page":"11440","DOI":"10.1073\/pnas.1708447114","article-title":"Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect","volume":"11","author":"Shukla","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"65","doi-asserted-by":"publisher","first-page":"12263","DOI":"10.1073\/pnas.192172299","article-title":"A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk","volume":"9","author":"Hunter","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"66","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1128\/MCB.15.4.2191","article-title":"Transcriptional regulation of estrogen receptor in breast carcinomas","volume":"1","author":"Weigel","year":"1995","journal-title":"Mol Cell Biol"},{"key":"67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/bcr452","article-title":"The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis","volume":"4","author":"Anderson","year":"2002","journal-title":"Breast Cancer Res"},{"key":"68","first-page":"515","article-title":"[Estrogen receptors and the mammary gland]","volume":"4","author":"Castro","year":"1997","journal-title":"Rev Invest Clin"},{"key":"69","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/mend.11.6.9891","article-title":"Mammary gland development is mediated by both stromal and epithelial progesterone receptors","volume":"1","author":"Rosen","year":"1997","journal-title":"Mol Endocrinol"},{"key":"70","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1677\/erc.1.00804","article-title":"Mammary developmental fate and breast cancer risk","volume":"1","author":"Medina","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"71","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/bcr1660","article-title":"Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment","volume":"9","author":"Lanari","year":"2007","journal-title":"Breast Cancer Res"},{"key":"72","first-page":"1","article-title":"Cancer\/testis (CT) antigens - a new link between gametogenesis and cancer","volume":"1","author":"Old","year":"2001","journal-title":"Cancer Immun"},{"key":"73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2867-5-4","article-title":"Cancer\/testis antigens and gametogenesis: a review and \u201cbrain-storming\u201d session","volume":"5","author":"Erenpreisa","year":"2005","journal-title":"Cancer Cell Int"},{"key":"74","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.1093\/nar\/gkm896","article-title":"Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors","volume":"3","author":"Lobanenkov","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"75","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1073\/pnas.86.8.2766","article-title":"Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms","volume":"8","author":"Sekiya","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0003-2697(91)90120-i","article-title":"Fast and sensitive silver staining of DNA in polyacrylamide gels","volume":"19","author":"Gresshoff","year":"1991","journal-title":"Anal Biochem"},{"key":"77","first-page":"790","article-title":"p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma","volume":"14","author":"Coggi","year":"1995","journal-title":"Am J Pathol"},{"key":"78","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/s0046-8177(96)90307-x","article-title":"Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up","volume":"2","author":"Harris","year":"1996","journal-title":"Hum Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:14:30Z","timestamp":1685114070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5,26]]}},"alternative-id":["28442"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28442","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]}}}